Sangamo Therapeutics (SGMO) 10-K/A 2003 FY Annual report (amended)

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.1

Certification Pursuant to 18 U.S.C. §1350, as Adopted
Pursuant to §906 of the Sarbanes-Oxley Act of 2002

        Each of the undersigned hereby certifies pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 in his capacity as an officer of Sangamo BioSciences, Inc. (the "Company"), that:

(1)

the Annual Report of the Company on Form 10-K/A for the period ending December 31, 2003, as filed with the Securities and Exchange Commission (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/  EDWARD O. LANPHIER II      Edward O. Lanphier II
President, Chief Executive Officer and Director
(Principal Executive Officer)
Date:    April 27, 2004

/s/  GREG S. ZANTE      Greg S. Zante
Senior Director, Finance and Administration
(Principal Financial and Accounting Officer)
Date:    April 27, 2004

QuickLinks

Exhibit 32.1